Corrigendum re "Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial" [Eur Urol 2019;76:823-30]

Affiliations

• ¹ Tampere University Hospital, Tampere, Finland. Electronic address: pirkko-liisa.kellokumpu-lehtinen@tuni.fi.
• ² Department of Surgery, Capio S.T. Görans Hospital, Stockholm, Sweden; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
• ³ Department of Radiation Sciences, Oncology, Umeå University Hospital, Umeå, Sweden.
• ⁴ Uppsala University Hospital, Uppsala, Sweden.
• ⁵ Sundsvall University Hospital, Sundsvall, Sweden.
• ⁶ Gävle Central Hospital, Gävle, Sweden.
• ⁷ Seinäjoki Central Hospital, Seinäjoki, Finland.
• ⁸ Växjö Central Hospital, Växjö, Sweden.
• ⁹ 4Pharma, Turku, Finland.
• ¹⁰ Karlstad Central Hospital, Karlstad, Sweden.